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Background: Healthy body weight (HBW) determination affects multiple aspects of eating disorder (ED) treatment.
For example, it can inform patients and providers as to when return of menses (ROM), an objective determinant of
health, can occur. Growth curves (GCs) are sensitive indicators of health in youth and when up to date provide
critical information regarding normal and expected trajectories of growth. Although not widely recommended as a
first line tool for HBW calculation, a GC guides providers selecting a HBW that is individualized to each patient. The
primary aim of this paper was to assess availability and feasibility of utilizing GC data for HBW prediction in
adolescents referred for an ED assessment. We also sought to determine how this calculation compared to the
standardized HBW calculation that uses mean body mass index (BMI) for age and how each of these numbers
compared to the actual weight at ROM.
Methods: A retrospective chart review was completed on outpatients assessed for EDs between January 2004 and
December 2006. A total of 102 patients met inclusion criteria. Demographic information, GC data, HBW predictions,
and menstrual history were analyzed. A comparison of predicted HBWs using the aforementioned calculations and
weight at ROM was performed using t-test analyses.
Results: Eighty-one patients (79.4%) had GC data available at assessment although HBW prediction was possible in only
24 patients (23.8%) due to poor GC completion. Of those 24 patients, 9 had ROM data available; no significant difference
between our predicted HBW and the weight at ROM was found in these patients. In cases where HBW predictions could
be compared using GC data and the BMI method, we found the GC calculation to be overall superior.
Conclusions: We found overall rates of GC completion to be very low in our patients, which in turn limited the
feasibility of relying on a GC for HBW calculation in ED patients. When complete, GCs provide accurate HBWs for most
patients with EDs although it is clear that secondary methods of calculation are required given the gaps in data
observed using this cohort.
Keywords: Adolescent medicine, Pediatric growth, Eating disordersBackground
It is estimated that 0.5% of adolescent females in the
United States suffer from anorexia nervosa (AN), 1-5%
from bulimia nervosa (BN), and even more who present
with subthreshold eating disorders (EDs) that do not meet
exact criteria of the Diagnostic and Statistical Manual of* Correspondence: mharrison@cheo.on.ca
1Department of Paediatrics, Children’s Hospital of Eastern Ontario, University
of Ottawa, 401 Smyth Road, Ottawa, ON, Canada
2Children’s Hospital of Eastern Ontario Regional Eating Disorder Program,
Ottawa, ON, Canada
Full list of author information is available at the end of the article
© 2013 Harrison et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
waiver (http://creativecommons.org/publicdom
stated.Mental Disorders, Fourth Edition (DSM-IV) for AN or BN
[1]. AN is a life-threatening, chronic disorder with devas-
tating and potentially irreversible medical consequences,
including cardiovascular complications, decreased bone
mineral density, structural and functional brain abnormal-
ities, and impaired growth and development [2]. Fortu-
nately, if addressed in a timely manner, the likelihood of
reversing or minimizing some of these consequences is im-
proved. As such, prompt recognition, referral, and subse-
quent treatment are crucial to help minimize potential
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ing childhood and adolescence, growth history is an im-
portant clinical tool in the context of ED assessment and
management [3,4]. Both the World Health Organization
(WHO) and the Centers for Disease Control and Preven-
tion (CDC) encourage the use of growth charts worldwide
in the routine monitoring of infants, children and adoles-
cents [5-7]. Growth curves are sensitive indicators of
health in children and adolescents that provide a stand-
ard of how children and adolescents should grow over
time. Trajectories of growth are most valuable when rep-
resented as multiple points over time, as they can allow
for early identification of potential health problems and
provide health care providers with an earlier opportunity
to screen for chronic illnesses and intervene or investi-
gate further as required [5,6]. Growth curves also provide
important information as it relates to ED diagnoses. For
example, a Swedish report, which involved the retro-
spective analysis of school health service growth charts of
young female students diagnosed with restrictive EDs,
clearly showed interruptions in normal growth parame-
ters and growth velocity in the months predating clinical
diagnosis; that is, two thirds of the weight deficit (i.e. the
deviation from the expected weight growth curve) and
60% of the height retardation was generated before the
onset of weight loss [8]. In another smaller retrospective
review of growth curves of female adolescents (mean age
13.3 years) with AN, growth arrest was again evident
prior to the onset of weight loss [9].
Given the complex and multifactorial nature of AN,
research into how we can best re-nourish patients is on-
going. One of the most basic questions first asked by pa-
tients and families after an assessment relates to the
amount of weight gain required to re-establish health. In
fact, many of our immediate clinical decisions for treat-
ment are influenced by this “number”, that is, the pa-
tient’s weight percentage of their target/healthy body
weight (HBW). If a patient is deemed dangerously low in
weight (for example, if their weight was less than 70% of
their expected weight), hospitalization would likely be
recommended. The “number” also has implications as to
the degree of medical risk associated with the early stages
of refeeding. Patients initiating treatment at dangerously
low weights are at increased risk of the refeeding syn-
drome and need to be monitored appropriately [2,10].
Thus, the manner by which we calculate a patient’s healthy
weight goal is critically important not only for our immedi-
ate clinical decisions, but for patients’ psychological well-
being as they attempt and begin to accept the notion of a
return to a higher weight.
Despite the fact that the establishment of a HBW is a
critical component in the successful management of ED
patients, there is debate as to how the “number” should
be best calculated [11]. Clinicians and researchers haveexplored different methods for calculating HBW, al-
though recent literature points to the Body Mass Index
(BMI) method as the primary method of choice when
dealing with both ED and non-ED adolescent popula-
tions [4,12]. The BMI method of calculating HBW in-
volves the use of CDC growth charts, whereby HBW is
the product of the patient’s current height (in m2) and
the 50th percentile BMI for a person of the same age
and gender [4,12]. The BMI method is considered more
developmentally appropriate, based on a review of 3 differ-
ent methods of HBW determination (the BMI method, the
McLaren method and the Moore method) in an adolescent
ED population [4]. The details of the McLaren method and
the Moore method are published elsewhere [12-14]. An-
other study compared the same 3 methods in a non-ED
adolescent population [12]. The authors concluded that
while all 3 methods seemed equally valid for children
under the age of 8 years, the BMI method was the only
one that could be consistently applied to all children aged
2 to 20 years. Another recommendation for HBW calcula-
tion has been to use a BMI percentile in the 14th to 39th
percentile range, making adjustments for prior weight, pu-
bertal stage and expected growth [3]. Despite the fact that
each of these studies raises valid arguments, there are po-
tential problems associated with these methodologies. As
an example, a recent study on adolescents with AN com-
mented on the fact that the BMI percentile ranges set out
by other studies are likely to be too wide to be useful in
clinical settings for individual patients, and that approxi-
mately 1 out of 5 (20%) patients are unlikely to reach re-
productive maturity if such guidelines are followed [15].
Anecdotally, this makes sense understanding that in any
adolescent population at a given age, there will be a per-
centage of patients whose HBW and BMI is lower than
the 50th percentile (i.e. patients who are naturally tall
and slim), and those who will need to have a BMI greater
the 50th percentile to have regular menses and not be
physically compromised (i.e. patients who are shorter and
heavier). In addition to each of these arguments, it has also
been suggested that pelvic ultrasound grading can be used
as a measure of reproductive maturity, and therefore, as a
means of helping to determine HBW [15]. If we consider
and accept menstruation as a vital component of healthy
development, then it stands to reason that this information
could play a role in answering questions related to what
our threshold should be for a minimal acceptable weight.
Taking all of this into consideration, completed and
up-to-date growth curves provide extremely valuable in-
formation on individual growth trajectories and should
be considered an important tool that can be used to help
estimate a patient’s predicted HBW. We propose that
in cases where an up-to-date growth curve exists, ana-
lysis of the patient’s growth curve should be the first-
line measure used to provide an accurate estimate of a
Harrison et al. BMC Family Practice 2013, 14:134 Page 3 of 9
http://www.biomedcentral.com/1471-2296/14/134patient’s HBW. By using an up-to-date growth curve with
multiple points documented over time, a clinician can
easily establish which percentiles a patient’s weight and
height were following prior to the onset of disease [16].
In most cases, it allows a clinician to easily estimate a pa-
tient’s HBW and provides a number that is specific to the
individual patient based upon their previous growth pa-
rameters, rather than on the population average for age
(i.e. the 50th percentile).
When accurately predicted, a HBW goal can help ad-
dress patient anxiety towards weight goals early in the
course of treatment by eliminating any uncertainties the
patient may have with respect to the amount of expected
weight gain. It also informs treatment decisions relating
to the intensity of services required, and may help pre-
dict a weight required for return of menses (ROM) - an
objective determinant of health in ED patients (indica-
tive of a sufficient accrual of body fat and restoration of
hormone levels to allow for the resumption of proper
menstrual functioning) [16,17]. The inherent difficulty
with this method lies not in the calculation, but in the
reality that patients presenting for ED assessments often
do so either without any documented prior growth his-
tory, or with growth charts that are incomplete or lim-
ited in the information provided.
The primary goal of this paper was therefore to explore
whether the use of a growth curve provided at the time of
assessment does in fact provide a feasible means of deter-
mining a HBW. We aimed to do this by 1) reviewing the
availability and comprehensiveness of adolescent growth
curve data of patients referred for a multidisciplinary
ED assessment; and by 2) examining the relationship be-
tween our predictions of HBW goals based on prior
growth curve data provided and ROM (an objective indica-
tor of healthy weight). We also compared our proposed
technique of HBW estimation, the “growth curve method”,
with the BMI method of weight goal calculation to com-
pare their accuracy.
Methods
This study involved a retrospective chart analysis of pa-
tients who presented for an outpatient ED assessment at
a Canadian tertiary care hospital over the course of a
three-year period. A data abstraction sheet was created
by the authors and trialed on 10% of patients to ensure
feasibility. Information relating to demographics, clinical
and medical variables present at assessment, diagnosis,
growth curve data, and medical indicators such as men-
strual status, were included in the data abstraction form.
This study was reviewed and approved by the Children’s
Hospital of Eastern Ontario (CHEO)’s Research Ethics
Board prior to data retrieval. Data was tabulated using
SPSS 17.0 and descriptive, frequency, and t-test analyses
were performed where appropriate.Participants
Participants consisted of all patients who presented to
the tertiary care facility for an outpatient ED assessment




Variables such as age at assessment, age of self-reported
ED onset (i.e. onset of ED behaviours such as calorie re-
striction, over-exercising), diagnosis at assessment, and
BMI (kg/m2), were noted.
Growth curve data
Abstracted data relating to growth curve information
included whether prediction of healthy body indices
was performed at assessment, whether growth curves
were available before and after assessment, who pro-
vided the growth curve data, how many data points
were available before and after ED onset, and whether
there was evidence of growth retardation, as indicated
by any significant deviance away from the patients’
expected growth curve based on his/her historical growth
curve data.
Healthy Body Weight Predictions
HBW predictions were performed by reviewing histor-
ical growth curve data prior to ED onset and noting the
percentile curves that patients’ weight and height were
previously following. We then extrapolated this to the
weight at that same percentile for current age. We also
extrapolated the patient’s previous BMI curve percentile
to the same percentile for current age. In our practice,
this HBW goal is the minimum number of a 2–3 kilo-
gram weight range that is set as the goal range. For the
purpose of this paper, we used this minimum target
weight to compare to weight at ROM. HBW predictions
were also made using the BMI method of calculating
HBW (i.e. using the 50th percentile BMI for exact age
and height on the CDC BMI-for-age percentile charts)
in order to compare the results of our proposed tech-
nique and this established method.
Results
Demographic and growth chart data
There were 115 patients assessed during the study time-
frame. Of those, 13 were excluded for various reasons: 8
patients (7.0%) were assessed on an emergency/inpatient
basis and therefore standard outpatient assessment data
was not obtained, 1 patient (0.9%) had no assessment
data available, and 4 patients (3.5%) were found to have
no ED diagnosis after assessment. This left a total of 102
patients for analysis and review. The majority (n = 94;
92%) of patients reviewed were female, and the mean age
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patients (28.4%) were diagnosed with AN, 23 patients
(22.5%) were diagnosed with BN, and the remaining 50
patients (49%) were given a diagnosis of eating disorder
not otherwise specified (EDNOS). Table 1 contains per-
tinent demographic characteristics of this sample sepa-
rated by gender.
Most of the data available for growth curves was pro-
vided by the patients’ primary care physician (86.6%),
although specialists (4.9%), family members (6.1%), and
self-reported data (2.4%), were also included. Eighty-
one participants (79.4%) had at least one growth curve
weight data point available for analysis (regardless of
whether the data was captured before or during the onset
of the ED), although 60% of all growth curves reviewed
contained 2 or fewer weight points at the time of assess-
ment (weight median 2.0, range 0 – 47). Clinically, this
would represent at most two weight points on a growth
curve, one of which would likely have been completed
as part of the referral process. When available, patient
weights were documented by primary health care pro-
viders on average 11.93 months (SD = 13.07 months) after
self-reported ED onset. Figure 1 shows the patient growth
curve availability.
Using growth curves for estimation of HBW goals
In an attempt to estimate how accurate the predicted
HBW was at the time of assessment, we compared the
HBW estimations provided at assessment to weights at
time of ROM in patients where data was available. Of
the female patients diagnosed with either AN or low-
weight EDNOS at assessment, only 26 patients had
secondary amenorrhea, were not taking any form of
contraceptive throughout the treatment course, and had
available weight data at the time ROM occurred. Of
these, only 11 patients (42%) had more than 2 weight
plots on their growth curve prior to the onset of the ED.
Two of these patients were excluded from further ana-
lysis as their pre-ED BMI and weights were greater than
the 95th percentile, making it extremely difficult to pre-
dict a HBW trajectory based upon ROM only. This leftTable 1 Means (SD) of gender-specific demographic character
Demographics Females
AN (n = 25) BN (n = 23)
Age of patient at assessment (yrs) 15.06 (1.76) 16.49 (1.08)
Age of patient at ED onset (yrs) 14.02 (1.73) 14.16 (1.72)
Chronicity of symptoms (yrs) 1.04 (.68) 2.33 (1.44)
Height at assessment (meters) 1.65 (.10) 1.64 (.06)
Weight at assessment (kg) 43.56 (7.92) 57.30 (7.60)
BMI at assessment (kg/m2) 15.84 (1.55) 21.41 (2.56)
BMI-SDS at assessment (kg/m2) −2.07 (.98) .09 (.76)just 9 patients who had appropriate pre-ED growth curve
data for an estimation of a HBW goal. Figure 2 explains
patient selection for comparison of predicted HBW at as-
sessment and weight at ROM. The results of the t-test did
not show any significant difference between the predicted
HBW at assessment (M = 55.98 kg, SD = 4.63) and the
weight at ROM (M = 56.04 kg, SD = 4.22) (t(8) = −0.094,
p = .927).
Results show that 8 (89%) patients experienced ROM
within 2 kg of the target weight set at assessment, while
the remaining patient had an estimation within 5 kg of
her weight at ROM. Of note, in the single outlier, her
growth curve did not contain any weight information for
the 6 years preceding the onset of illness. Each patient
whose predicted HBW was within 2 kg of their weight
at ROM had at least one weight plot within 1 to 2 years
prior to ED onset.
A comparison between the growth curve method and
the BMI method is shown in Table 2. Overall, a descrip-
tive look at the table demonstrates that the growth curve
method generally provides a HBW estimation that is
closer to the weight at ROM than does the BMI method.
This can be seen when reviewing the difference scores
between the two methods. On average, the growth curve
method generated HBWs that were 0.067 kg greater
than the weight at ROM, whereas the BMI method gen-
erated HBWs that were 2.178 kg greater than the weight
at ROM. Also interesting is the range of scores that
emerged using the two different methods. With the
growth curve method, the predictions ranged from being
under-estimated by 2 kg to an overestimation of 5 kg.
With the BMI method, the predictions range from being
underestimated by 4.2 kg to an overestimation of 8.1 kg.
Although these comparisons are only available for a
small number of individuals (n = 9), thereby affecting the
ability to perform statistically meaningful comparisons
across the methods, this provides some preliminary de-
scriptive data on the accuracy of HBW predictions using
the different methods. The comparison of the growth
curve method and BMI method of weight goal predic-
tions as they relate to ROM is depicted in Figure 3.istics described per diagnostic category
Males
EDNOS (n = 46) AN (n = 4) BN (n = 0) EDNOS (n = 4)
15.41 (1.29) 15.06 (1.01) – 13.98 (.87)
13.40 (1.62) 14.14 (1.22) – 13.35 (.96)
2.01 (1.30) .92 (.22) – .62 (.26)
1.64 (.07) 1.65 (.07) – 1.64 (.10)
52.07 (8.02) 46.10 (5.36) – 49.10 (7.11)
19.39 (2.78) 16.87 (1.77) – 18.20 (.71)
-.45 (1.04) −1.61 (1.44) – -.43 (.41)
Figure 1 Growth curve availability.
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Our data suggests that the majority of patients referred
for an ED assessment have incomplete growth curves.
Despite a mean age of 15.5 yrs at assessment, the major-
ity of patients presented with 2 or less growth curve
weight plots prior to ED onset, suggesting either a lowFigure 2 Flowchart of patient selection for comparison of predicted Hnumber of medical doctor (MD) visits during the child-
hood and adolescent years and/or incomplete data collec-
tion at the time of the MD visit. Literature reviewing how
often patient growth charts are kept up-to-date is sparse.
Two studies performed in the pediatric inpatient setting
found that rates of documentation of growth parametersBW at assessment and BMI at ROM.
Table 2 Assessment and predicted weight characteristics, and the difference scores between methods of prediction






















1 49.9 165.4 18.2 −0.99 60.0 57.0 60.0 .00 3.00
2 40.7 160.0 15.7 −1.54 59.0 48.9 57.0 −2.00 8.10
3 46.0 172.8 15.4 −2.63 63.8 60.5 62.3 −1.50 1.80
4 46.9 162.3 17.8 −0.04 51.5 50.0 49.6 −1.90 -.40
5 46.0 167.0 16.5 −1.63 53.0 55.6 58.0 5.00 2.40
6 57.1 172.0 19.3 −0.46 58.0 60.8 57.5 -.50 −3.30
7 39.4 149.0 15.6 −1.23 50.0 43.5 50.7 .70 7.20
8 40.8 165.0 15.1 −3.48 52.0 57.0 52.8 .80 −4.20
9 37.3 166.0 13.5 −2.82 56.5 51.5 56.5 .00 5.00
Average 44.9 164.4 16.3 −1.65 55.98 53.89 56.04 .067 2.18
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primary care setting, it has been shown that many prac-
titioners report not measuring children at every health
visit and when measured, the data is often not plotted
or analyzed on growth curves [20,21]. This is concerning
because of the potential delay in the diagnosis of a
variety of illnesses that impair growth. Moreover, our
observation that patient weights were only documented,
on average, approximately one year after self-reported
ED onset further highlights the importance of annual
health screenings.
Although the sample of patients with sufficient growth
curve data deemed necessary to calculate an estimated
target weight was very small in our study (35%), we were
able to demonstrate good utility when completed and up-
to-date growth curves were available for patients with AN/Figure 3 Differences between weight at return of menses (ROM) in co
body weight (HBW) prediction.restrictive EDNOS. Although we cannot comment defini-
tively based upon our low sample size, it makes clinical
sense that the sensitivity of such predictions would only
improve when growth curves contain more data points for
height and weight and are completed on an annual basis.
Unfortunately, there is no current consensus among
providers regarding an ideal method of HBW calculation
in patients with EDs [11]. Research into this area, while
limited, has explored the utility of the BMI, McLaren,
and Moore methods of HBW calculation, as well as other
methods such as pelvic ultrasound grading, in both ED
and non-ED adolescent and adult populations [3,4,12,15].
While no clear consensus has been established, the BMI
method (i.e. the use of BMI growth curves) is starting
to emerge as a primary choice among researchers for
HBW calculations in clinical and non-clinical children andmparison to the growth curve (GC) and BMI method of healthy
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jective indicator of weight restoration, although many
would argue that this alone may be insufficient. Of the
studies that have been completed as a means of addressing
this question, most have shown that menses returns at an
average weight around 90% of an estimated HBW [22-25].
It is important to note, however, that the means by which
the HBW was calculated in these studies varied, although
authors typically did so using the median weight for height
and/or age as the reference point for calculation. Given the
number of confounders associated with this issue, it is
not surprising that the level of individual variation is
considerable. For example, several authors have shown
that anywhere from 5% to over 30% of patients remain
amenorrheic once they reach 90% of their estimated
“normal” body weight [22-25]. In one study, 48% of
patients who resumed menses did so at a weight less
than 90% of the “standard body weight” (range 75 to
115%) [23]. Another study showed that ROM occurred at a
weight above the population average in 31% of patients
[16]. Clearly, further research into this area is required. To
our knowledge, there are no other publications using his-
torical growth curve data as a means of estimating HBW,
nor comparing it to HBW based on ROM. We were also
unable to find any published reference on how calculation
differences (i.e. using growth curves alone vs. standardized
calculation of percentile of BMI) influence rates at which
ROM is demonstrated. It is also important to note that it is
unclear how close the correlation between BMI and ROM
is expected to be. There is a complex relationship between
leptin, adiponectin, inhibin B, ghrelin and a disrupted
hypothalamic regulation of menstruation that likely effects
the direct correlation between BMI and ROM [26].
We believe that our data, despite its limitations, shows
obvious merit in the argument that growth curves should
be used as a first line to predict HBW whenever sufficient
data is available and allows for accurate prediction. We
have shown in our small sample that using historical
growth curve data to predict HBW goals is more accurate
than using the BMI method of calculation. Although a
small sample, the implications for the individual patients
are note-worthy. For example, the HBW prediction done
by the BMI method for one of our patients was 7.2 kg
lower than the weight required for ROM, and 0.7 kg lower
when done by the growth curve method. Another patient’s
predicted HBW goal done by the BMI method was 8.1 kg
below the weight required for ROM, as compared to 2 kg
above the target when done by growth curve method.
Clinically, overshooting and undershooting these weight
goals for patients can lead to distrust of the treatment team
and plan, as well as unneeded patient anxiety. As such, we
recommend that ED clinicians make every possible effort
to gather prior growth information at the time a first as-
sessment is completed. Our own program has made itmandatory for all referred patients to have a completed
growth curve sent in at the time of referral, although it is
clear, based upon this study, that the majority of providers
are not collecting such data longitudinally. We also recom-
mend clinicians use any other means available, such as
reviewing old hospital charts, triage visit records from
emergency department visits, as well as having the family
provide data whenever possible. Only after this method has
been exhausted and/or deemed not applicable should we
look at other methods of calculating HBWs. It is important
to note that in growing and developing youth, HBW goals
need to be continually adjusted as height increases, to
maintain the same goal BMI percentile. Using historical
growth curve data is of course limited to having data avail-
able, and our study has shown that growth curves in this
population are often not complete. In those cases, the BMI
method of HBW calculation can be used. Another noted
limitation to our method involves HBW predictions for pa-
tients who were overweight prior to ED onset. We re-
moved 2 patients from analysis because their pre-ED BMIs
were greater than the 95 percentile for age. In those cases,
weight trajectory as seen on growth curves are of limited
use with our method of HBW goal prediction. In those
cases as well, perhaps the BMI method of calculation is
most appropriate. Further research is required exploring
accurate methods of estimating HBW for those who were
overweight prior to ED onset, as well as for males and pre-
menarchal females.
It should be stated that, as is typically the case with
pediatric ED populations [27], the observed proportion
of EDNOS patients in this study is much greater than
that of both the AN and BN patients, although this does
not limit the representativeness of the findings. A diag-
nosis of EDNOS is given to patients who do not exactly
meet the strict criteria set forth by the DSM-IV for a
diagnosis of either AN or BN, and it is this diagnostic
category that predominates the treatment-seeking ado-
lescent ED population [27]. Additionally, for the pur-
poses of this study, the population of interest consisted
of patients with AN and those with restrictive EDNOS,
as the determination of a “healthy weight” is most rele-
vant for these patients at the time of assessment.
Limitations of our study include the fact that it was
retrospective in nature and relied upon chart review. As
noted above, the use of ROM as the primary indicator of
heath is limited for a variety of different reasons, although
this alone would suggest that patients have regained suffi-
cient fat stores and hormone levels to allow menstrual
functioning to resume. Although used as a marker of
health in ED patients in this study, ROM should be
regarded as the first step required for maintenance of
medical health, as one of the primary goals of treatment
is to re-establish regular ovulatory menstrual cycles [16].
We were also limited in our analysis of the reliability of
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completed with sufficient data points. Non-significant re-
sults may also have been found due to the small sample
size available for this study.
Conclusions
Adolescents presenting with EDs have limited growth
curve data available at the time of assessment, which
makes it challenging to uniformly utilize this tool to esti-
mate a HBW goal. Despite this, the use of growth curves
to estimate HBW in adolescents with AN or restrictive
EDNOS should be considered whenever possible. When
this method is not possible (i.e. due to incomplete growth
charts), it becomes important to then use an alternative
method (e.g. the 50th percentile BMI method) that has
shown some clinical merit. In these cases, clinicians
should be aware of the limitations of the selected method
and use other clinical indicators such as ROM to help
guide final decisions.
This study also suggests that we need to put greater
emphasis on anticipatory screening and the importance
of annual health checks for all youth. At those visits,
health care practitioners should make a point of always
collecting weight and height data as a means of facilitating
the completion of growth curves. In addition, the public
should continue to be educated regarding the merit of an-
ticipatory guidance and regular annual medical visits with
primary care providers across all ages, in order to ensure
all developmental and physical milestones are being met.
More prospective research is needed regarding an optimal
means of calculating HBW goals for children and adoles-
cents with EDs.
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